Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...

but especially something called glutamate excitotoxicity, where a level of a particular neurotransmitter in the brain called glutamate can rise to a level 100 times its baseline. “We see high ...

New research identifies key cellular mechanism driving Alzheimer's disease The breakthrough marks a promising target for drug therapies that slow, possibly reverse, the disease's development Date: ...

Background: Salvianolic acid B (Sal B) is potentially the most valuable water-soluble active component in Salvia miltiorrhiza. Its chemical formula contains multiple phenolic hydroxyl groups, so it ...

VRAC plays a dual role in ischemia-reperfusion injury: on the one hand, activated VRAC promotes the release of intracellular chloride and glutamate, exacerbating cellular swelling and excitotoxicity, ...